264 related articles for article (PubMed ID: 9823469)
1. Dysregulation of the E-cadherin/catenin complex by irreversible mutations in human carcinomas.
Berx G; Nollet F; van Roy F
Cell Adhes Commun; 1998; 6(2-3):171-84. PubMed ID: 9823469
[TBL] [Abstract][Full Text] [Related]
2. Alterations of E-cadherin and beta-catenin in gastric cancer.
Huiping C; Kristjansdottir S; Jonasson JG; Magnusson J; Egilsson V; Ingvarsson S
BMC Cancer; 2001; 1():16. PubMed ID: 11747475
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.
Sarrió D; Moreno-Bueno G; Hardisson D; Sánchez-Estévez C; Guo M; Herman JG; Gamallo C; Esteller M; Palacios J
Int J Cancer; 2003 Aug; 106(2):208-15. PubMed ID: 12800196
[TBL] [Abstract][Full Text] [Related]
4. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
6. No evidence for mutations in the alpha- and beta-catenin genes in human gastric and breast carcinomas.
Candidus S; Bischoff P; Becker KF; Höfler H
Cancer Res; 1996 Jan; 56(1):49-52. PubMed ID: 8548773
[TBL] [Abstract][Full Text] [Related]
7. Adenomatous polyposis coli gene, beta-catenin, and E-cadherin expression in proximal and distal gastric cancers and precursor lesions: an immunohistochemical study using tissue microarrays.
Gulmann C; Grace A; Leader M; Butler D; Patchett S; Kay E
Appl Immunohistochem Mol Morphol; 2003 Sep; 11(3):230-7. PubMed ID: 12966349
[TBL] [Abstract][Full Text] [Related]
8. Expression of the E-cadherin-catenin complex in lung neuroendocrine tumours.
Clavel CE; Nollet F; Berx G; Tejpar S; Nawrocki-Raby B; Kaplan HH; van Roy FM; Birembaut PL
J Pathol; 2001 May; 194(1):20-6. PubMed ID: 11329137
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
10. Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines.
Yang SZ; Kohno N; Yokoyama A; Kondo K; Hamada H; Hiwada K
Int J Oncol; 2001 Mar; 18(3):541-8. PubMed ID: 11179484
[TBL] [Abstract][Full Text] [Related]
11. The role of the E-cadherin/catenin complex in gastrointestinal cancer.
Debruyne P; Vermeulen S; Mareel M
Acta Gastroenterol Belg; 1999; 62(4):393-402. PubMed ID: 10692769
[TBL] [Abstract][Full Text] [Related]
12. Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines.
Pierceall WE; Woodard AS; Morrow JS; Rimm D; Fearon ER
Oncogene; 1995 Oct; 11(7):1319-26. PubMed ID: 7478552
[TBL] [Abstract][Full Text] [Related]
13. Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach.
Kim HS; Hong EK; Park SY; Kim WH; Lee HS
Anticancer Res; 2003; 23(3C):2863-8. PubMed ID: 12926124
[TBL] [Abstract][Full Text] [Related]
14. Abnormal expression and function of the E-cadherin-catenin complex in gastric carcinoma cell lines.
Jawhari AU; Noda M; Farthing MJ; Pignatelli M
Br J Cancer; 1999 May; 80(3-4):322-30. PubMed ID: 10408833
[TBL] [Abstract][Full Text] [Related]
15. Cadherin and catenin alterations in human cancer.
Hajra KM; Fearon ER
Genes Chromosomes Cancer; 2002 Jul; 34(3):255-68. PubMed ID: 12007186
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the human E-cadherin (CDH1) gene.
Berx G; Becker KF; Höfler H; van Roy F
Hum Mutat; 1998; 12(4):226-37. PubMed ID: 9744472
[TBL] [Abstract][Full Text] [Related]
17. The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer.
Nollet F; Berx G; van Roy F
Mol Cell Biol Res Commun; 1999 Aug; 2(2):77-85. PubMed ID: 10542129
[TBL] [Abstract][Full Text] [Related]
18. The interactions of APC, E-cadherin and beta-catenin in tumour development and progression.
Ilyas M; Tomlinson IP
J Pathol; 1997 Jun; 182(2):128-37. PubMed ID: 9274521
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner.
Gottardi CJ; Wong E; Gumbiner BM
J Cell Biol; 2001 May; 153(5):1049-60. PubMed ID: 11381089
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast.
Mastracci TL; Tjan S; Bane AL; O'Malley FP; Andrulis IL
Mod Pathol; 2005 Jun; 18(6):741-51. PubMed ID: 15696125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
